Publications by authors named "Paul Rowe"

Claim this Profile
P
Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies.
Martin Desrosiers, Scott Nash, Andrew Lane, Stella E Lee, Eugenio De Corso, Paul J Rowe

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving health equity in immune disease: leveraging big data and artificial intelligence in an evolving health system landscape.
Stan Kachnowski, Asif H Khan, Shadé Floquet, Kendal K Whitlock, Juan Pablo Wisnivesky, Paul Rowe

Front Big Data· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies.
Martin Desrosiers, Scott Nash, Andrew Lane, Stella E Lee, Eugenio De Corso, Paul J Rowe

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dupilumab on small airways measured by airway oscillometry in VESTIGE.
George R Washko, Brian J Lipworth, Dinesh Saralaya, Mei Zhang, Paul J Rowe

J Allergy Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthma.
William W Busse, Monica Kraft, Christian Domingo, Inés de Mir-Messa, Diego J Maselli, Paul J Rowe

J Asthma· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE Trial.
Celeste Porsbjerg, Eleanor M Dunican, Njira L Lugogo, Mario Castro, Alberto Papi, Paul J Rowe

Am J Respir Crit Care Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps.
Anju T Peters, Jayant M Pinto, Kathleen M Buchheit, Sietze Reitsma, Andrew Thamboo, Paul J Rowe

Allergy Asthma Proc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions.
Ian D Pavord, Michael E Wechsler, William W Busse, Christian Domingo, Changming Xia, Paul J Rowe

J Allergy Clin Immunol Glob· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of Fractional Exhaled Nitric Oxide and Its Relationship With Exacerbation in Patients Aged 6 Years or Older With Uncontrolled, Moderate-to-Severe Asthma.
William W Busse, Ian D Pavord, Michael E Wechsler, Ignacio J Davila, Arman Altincatal, Paul J Rowe

Chest· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD.
Bartolome R Celli, Antonio Anzueto, Dave Singh, Nicola A Hanania, Leonardo Fabbri, Paul J Rowe

Chest· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Smoker: A Clinical Chronic Obstructive Pulmonary Disease Phenotype Affecting Disease Progression and Response to Therapy.
Bartolome R Celli, Stephanie A Christenson, Klaus F Rabe, MeiLan K Han, Maarten van den Berge, Paul J Rowe

Am J Respir Crit Care Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE.
Daniel J Jackson, Eckard Hamelmann, Graham Roberts, Leonard B Bacharier, Changming Xia, Paul J Rowe

J Allergy Clin Immunol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial.
Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira L Lugogo, Christopher E Brightling, Paul J Rowe

Lancet Respir Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.
Njira L Lugogo, Xavier Soler, Yasuhiro Gon, Andréanne Côté, Ole Hilberg, Paul J Rowe

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps.
Zachary M Soler, Zara M Patel, Joaquim Mullol, Jose Mattos, Scott Nash, Paul Rowe

Am J Rhinol Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab.
Claus Bachert, Asif H Khan, Claire Hopkins, Joseph K Han, Wytske J Fokkens, Paul J Rowe

Ann Allergy Asthma Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma.
Ian D Pavord, Klaus F Rabe, Elliot Israel, Stanley J Szefler, Guy Brusselle, Paul J Rowe

J Allergy Clin Immunol Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab improves sense of smell and clinical outcomes in patients with severe chronic rhinosinusitis with nasal polyps with anosmia.
Andrew P Lane, Joaquim Mullol, Claire Hopkins, Wytske J Fokkens, Stella E Lee, Paul J Rowe

Curr Med Res Opin· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP.
Claus Bachert, Asif H Khan, Wytske J Fokkens, Claire Hopkins, Philippe Gevaert, Paul J Rowe

J Allergy Clin Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE).
Jorge F Maspero, Martti A Antila, Antoine Deschildre, Leonard B Bacharier, Arman Altincatal, Paul J Rowe

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab 200 mg was efficacious in children (6-11 years) with moderate-to-severe asthma for up to 2 years: EXCURSION open-label extension study.
Wanda Phipatanakul, Christian Vogelberg, Leonard B Bacharier, Sharon Dell, Arman Altincatal, Paul J Rowe

Pediatr Pulmonol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics.
Michael E Wechsler, Linda Rogers, G Walter Canonica, Arnaud Bourdin, Arman Altincatal, Paul J Rowe

ERJ Open Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.
Claus Bachert, Philippe Gevaert, Brian Lipworth, Syed Shahzad Mustafa, Andrew P Lane, Paul Rowe

Allergy· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS-52 trial.
Wytske J Fokkens, Claus Bachert, Claire Hopkins, Osama Marglani, Amy Praestgaard, Paul J Rowe

Clin Transl Immunology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.
Nijra L Lugogo, Enrico Heffler, Vicente Plaza, Ole Hilberg, Changming Xia, Paul J Rowe

J Asthma Allergy· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis